129 related articles for article (PubMed ID: 16254400)
1. Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer's disease.
Buchert R; Wilke F; Chakrabarti B; Martin B; Brenner W; Mester J; Clausen M
J Neuroimaging; 2005 Oct; 15(4):348-55. PubMed ID: 16254400
[TBL] [Abstract][Full Text] [Related]
2. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
[TBL] [Abstract][Full Text] [Related]
3. Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
Buchholz HG; Wenzel F; Gartenschläger M; Thiele F; Young S; Reuss S; Schreckenberger M
Biomed Eng Online; 2015 Aug; 14():79. PubMed ID: 26281849
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
[TBL] [Abstract][Full Text] [Related]
6. Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease.
Dubois A; Hérard AS; Delatour B; Hantraye P; Bonvento G; Dhenain M; Delzescaux T
Neuroimage; 2010 Jun; 51(2):586-98. PubMed ID: 20206704
[TBL] [Abstract][Full Text] [Related]
7. Complementarity of visual and voxel-based FDG-PET analysis to detect MCI-like hypometabolic pattern in elderly patients with hypertension and isolated memory complaints.
Van Der Gucht A; Verger A; Yagdigul Y; Poussier S; Joly L; Watfa G; Benetos A; Karcher G; Marie PY
Acta Radiol; 2015 Aug; 56(8):980-9. PubMed ID: 25085109
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new expert system for fully automated detection of the Alzheimer's dementia pattern in FDG PET.
von Borczyskowski D; Wilke F; Martin B; Brenner W; Clausen M; Mester J; Buchert R
Nucl Med Commun; 2006 Sep; 27(9):739-43. PubMed ID: 16894329
[TBL] [Abstract][Full Text] [Related]
9. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
[TBL] [Abstract][Full Text] [Related]
10. FDG PET imaging in patients with pathologically verified dementia.
Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
[TBL] [Abstract][Full Text] [Related]
11. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment.
Wu X; Chen K; Yao L; Ayutyanont N; Langbaum JB; Fleisher A; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Foster NL; Thompson PM; Harvey DJ; Weiner MW; Koeppe RA; Jagust WJ; Reiman EM;
J Neurosci Methods; 2010 Oct; 192(2):277-85. PubMed ID: 20678521
[TBL] [Abstract][Full Text] [Related]
12. Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD.
Gallivanone F; Della Rosa PA; Castiglioni I
Curr Alzheimer Res; 2016; 13(6):682-94. PubMed ID: 26567733
[TBL] [Abstract][Full Text] [Related]
13. B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis.
Wenzel F; Young S; Wilke F; Apostolova I; Arlt S; Jahn H; Thiele F; Buchert R
Neuroimage; 2010 Apr; 50(3):994-1003. PubMed ID: 20053378
[TBL] [Abstract][Full Text] [Related]
14. Differentiating the frontal presentation of Alzheimer's disease with FDG-PET.
Woodward MC; Rowe CC; Jones G; Villemagne VL; Varos TA
J Alzheimers Dis; 2015; 44(1):233-42. PubMed ID: 25261443
[TBL] [Abstract][Full Text] [Related]
15. Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease.
Foster NL; Wang AY; Tasdizen T; Fletcher PT; Hoffman JM; Koeppe RA
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S29-36. PubMed ID: 18631997
[TBL] [Abstract][Full Text] [Related]
16. Topographic patterns of brain functional impairment progression according to clinical severity staging in 116 Alzheimer disease patients: FDG-PET study.
Choo IH; Lee DY; Youn JC; Jhoo JH; Kim KW; Lee DS; Lee JS; Woo JI
Alzheimer Dis Assoc Disord; 2007; 21(2):77-84. PubMed ID: 17545731
[TBL] [Abstract][Full Text] [Related]
17. Validation of
Presotto L; Ballarini T; Caminiti SP; Bettinardi V; Gianolli L; Perani D
Neuroinformatics; 2017 Apr; 15(2):151-163. PubMed ID: 28063108
[No Abstract] [Full Text] [Related]
18. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
Foster NL; Heidebrink JL; Clark CM; Jagust WJ; Arnold SE; Barbas NR; DeCarli CS; Turner RS; Koeppe RA; Higdon R; Minoshima S
Brain; 2007 Oct; 130(Pt 10):2616-35. PubMed ID: 17704526
[TBL] [Abstract][Full Text] [Related]
19. Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18.
Zahn R; Juengling F; Bubrowski P; Jost E; Dykierek P; Talazko J; Huell M
Psychiatry Res; 2004 Dec; 132(2):159-72. PubMed ID: 15598550
[TBL] [Abstract][Full Text] [Related]
20. Multi-center study on Alzheimer's disease using FDG PET: group and individual analyses.
Yuan X; Shan B; Ma Y; Tian J; Jiang K; Cao Q; Wang R
J Alzheimers Dis; 2010; 19(3):927-35. PubMed ID: 20157248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
